Targeting DNA Ligase III Addiction in T-Cell Acute Lymphoblastic Leukemia by the Natural Flavonoid Rhamnetin
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy with dismal outcomes in relapsed/refractory settings, where nelarabine remains the sole approved agent with limited frontline efficacy. Genomic instability in T-ALL is sustained by a rewired DNA repair network, yet the functional reliance on DNA Ligase III (LIG3)-dependent alternative non-homologous end joining remains largely unexplored. By interrogating public transcriptomic cohorts, functional DepMap datasets, and siRNA-mediated knockdown, we evaluated LIG3 expression and essentiality in T-ALL. Pharmacological targeting was evaluated using Rhamnetin (RHM), a previously characterized LIG3-binding flavonoid, alone or combined with nelarabine across T-ALL cell lines and healthy peripheral blood mononuclear cells. LIG3 mRNA was uniformly expressed across T-ALL oncogenic subgroups. Functional assays confirmed LIG3 essentiality in T-ALL models. RHM dose-dependently reduced viability and clonogenic potential while sparing healthy cells. Mechanistically, RHM triggered a canonical DNA damage response with CHK1/CHK2 phosphorylation and γH2AX accumulation, driving CDC25A down-regulation, cell cycle perturbation, and apoptosis. Furthermore, RHM enhanced the anti-leukemic efficacy of nelarabine, displaying synergistic to additive interactions. These findings suggest LIG3 as an actionable dependency in T-ALL cells and support LIG3 inhibition, alone or combined with nelarabine, for therapeutic development.
Authors
- Pierosandro Tagliaferri (ORCID: https://orcid.org/0000-0002-1535-2477)
- Emanuela Altomare (ORCID: https://orcid.org/0000-0002-0772-9676)
- Katia Grillone (ORCID: https://orcid.org/0000-0003-0268-5536)
- Licia Pensabene (ORCID: https://orcid.org/0000-0003-2043-5530)
- Serena Ascrizzi (ORCID: https://orcid.org/0000-0002-7741-4119)
- Stefania Signorelli (ORCID: https://orcid.org/0000-0002-3906-8155)
- Pierfrancesco Tassone (ORCID: https://orcid.org/0000-0002-8298-6787)
- Nicoletta Polerà (ORCID: https://orcid.org/0000-0002-0636-0774)
- Giada Juli (ORCID: https://orcid.org/0000-0002-5317-6144)
- Daniele Caracciolo (ORCID: https://orcid.org/0000-0001-7870-7565)
- Sara Squillacioti
- Maria Gaetano (ORCID: https://orcid.org/0009-0005-3166-8614)
- Amalia Gagliardi
Institutions
- Magna Graecia University (IT)
- Institute for Biomedical Research and Innovation (IT)
- National Research Council (IT)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2026-11-12
- DOI
- https://doi.org/10.3390/ijms272210148
- Primary Topic
- Acute Lymphoblastic Leukemia research
- Type
- article
- Field-Weighted Citation Impact
- 0.00